UniProt ID | CPSF6_HUMAN | |
---|---|---|
UniProt AC | Q16630 | |
Protein Name | Cleavage and polyadenylation specificity factor subunit 6 {ECO:0000305} | |
Gene Name | CPSF6 {ECO:0000312|HGNC:HGNC:13871} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 551 | |
Subcellular Localization | Nucleus . Nucleus, nucleoplasm . Nucleus speckle . Cytoplasm . Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm) (PubMed:19864460). | |
Protein Description | Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. [PubMed: 9659921] | |
Protein Sequence | MADGVDHIDIYADVGEEFNQEAEYGGHDQIDLYDDVISPSANNGDAPEDRDYMDTLPPTVGDDVGKGAAPNVVYTYTGKRIALYIGNLTWWTTDEDLTEAVHSLGVNDILEIKFFENRANGQSKGFALVGVGSEASSKKLMDLLPKRELHGQNPVVTPCNKQFLSQFEMQSRKTTQSGQMSGEGKAGPPGGSSRAAFPQGGRGRGRFPGAVPGGDRFPGPAGPGGPPPPFPAGQTPPRPPLGPPGPPGPPGPPPPGQVLPPPLAGPPNRGDRPPPPVLFPGQPFGQPPLGPLPPGPPPPVPGYGPPPGPPPPQQGPPPPPGPFPPRPPGPLGPPLTLAPPPHLPGPPPGAPPPAPHVNPAFFPPPTNSGMPTSDSRGPPPTDPYGRPPPYDRGDYGPPGREMDTARTPLSEAEFEEIMNRNRAISSSAISRAVSDASAGDYGSAIETLVTAISLIKQSKVSADDRCKVLISSLQDCLHGIESKSYGSGSRRERSRERDHSRSREKSRRHKSRSRDRHDDYYRERSRERERHRDRDRDRDRERDREREYRHR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Phosphorylation | GHDQIDLYDDVISPS CCCCCCCCCCCCCCC | 13.32 | 26074081 | |
38 | Phosphorylation | DLYDDVISPSANNGD CCCCCCCCCCCCCCC | 16.79 | 26657352 | |
40 | Phosphorylation | YDDVISPSANNGDAP CCCCCCCCCCCCCCC | 36.52 | 26074081 | |
52 | Phosphorylation | DAPEDRDYMDTLPPT CCCCCCCCHHCCCCC | 9.59 | 23532336 | |
55 | Phosphorylation | EDRDYMDTLPPTVGD CCCCCHHCCCCCCCC | 25.32 | 19664995 | |
74 | Phosphorylation | GAAPNVVYTYTGKRI CCCCCEEEEECCCEE | 6.97 | 21945579 | |
75 | Phosphorylation | AAPNVVYTYTGKRIA CCCCEEEEECCCEEE | 11.73 | 21945579 | |
76 | Phosphorylation | APNVVYTYTGKRIAL CCCEEEEECCCEEEE | 8.87 | 21945579 | |
77 | Phosphorylation | PNVVYTYTGKRIALY CCEEEEECCCEEEEE | 28.55 | 21945579 | |
79 (in isoform 3) | Ubiquitination | - | 32.60 | 21890473 | |
79 (in isoform 2) | Ubiquitination | - | 32.60 | 21890473 | |
79 (in isoform 1) | Ubiquitination | - | 32.60 | 21890473 | |
79 | Ubiquitination | VVYTYTGKRIALYIG EEEEECCCEEEEEEC | 32.60 | 27667366 | |
79 | Acetylation | VVYTYTGKRIALYIG EEEEECCCEEEEEEC | 32.60 | 23954790 | |
137 | Phosphorylation | GVGSEASSKKLMDLL ECCCHHHHHHHHHHH | 40.64 | 21712546 | |
138 | Malonylation | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 26320211 | |
138 | Acetylation | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 25953088 | |
138 | Ubiquitination | VGSEASSKKLMDLLP CCCHHHHHHHHHHHC | 47.64 | 33845483 | |
146 | Ubiquitination | KLMDLLPKRELHGQN HHHHHHCHHHHCCCC | 59.48 | 29967540 | |
157 | Phosphorylation | HGQNPVVTPCNKQFL CCCCCCCCCCCHHHH | 23.51 | 30916345 | |
161 (in isoform 1) | Ubiquitination | - | 49.49 | 21890473 | |
161 (in isoform 3) | Ubiquitination | - | 49.49 | 21890473 | |
161 (in isoform 2) | Ubiquitination | - | 49.49 | 21890473 | |
161 | Acetylation | PVVTPCNKQFLSQFE CCCCCCCHHHHHHHH | 49.49 | 25953088 | |
161 | Ubiquitination | PVVTPCNKQFLSQFE CCCCCCCHHHHHHHH | 49.49 | 27667366 | |
165 | Phosphorylation | PCNKQFLSQFEMQSR CCCHHHHHHHHHHCC | 33.83 | 17525332 | |
169 | Sulfoxidation | QFLSQFEMQSRKTTQ HHHHHHHHHCCCCCC | 4.65 | 21406390 | |
174 | Phosphorylation | FEMQSRKTTQSGQMS HHHHCCCCCCCCCCC | 29.02 | 22210691 | |
175 | Phosphorylation | EMQSRKTTQSGQMSG HHHCCCCCCCCCCCC | 24.63 | 22210691 | |
177 | Phosphorylation | QSRKTTQSGQMSGEG HCCCCCCCCCCCCCC | 28.97 | 28111955 | |
180 | Sulfoxidation | KTTQSGQMSGEGKAG CCCCCCCCCCCCCCC | 6.75 | 30846556 | |
181 | Phosphorylation | TTQSGQMSGEGKAGP CCCCCCCCCCCCCCC | 26.29 | 22210691 | |
185 (in isoform 2) | Ubiquitination | - | 45.96 | 21890473 | |
185 | Ubiquitination | GQMSGEGKAGPPGGS CCCCCCCCCCCCCCC | 45.96 | 27667366 | |
185 | Acetylation | GQMSGEGKAGPPGGS CCCCCCCCCCCCCCC | 45.96 | 25953088 | |
185 (in isoform 1) | Ubiquitination | - | 45.96 | 21890473 | |
192 | Phosphorylation | KAGPPGGSSRAAFPQ CCCCCCCCCCCCCCC | 23.67 | 28111955 | |
193 | Phosphorylation | AGPPGGSSRAAFPQG CCCCCCCCCCCCCCC | 29.25 | 28111955 | |
194 | Methylation | GPPGGSSRAAFPQGG CCCCCCCCCCCCCCC | 31.47 | - | |
202 | Methylation | AAFPQGGRGRGRFPG CCCCCCCCCCCCCCC | 38.16 | - | |
204 | Methylation | FPQGGRGRGRFPGAV CCCCCCCCCCCCCCC | 31.58 | - | |
206 | Methylation | QGGRGRGRFPGAVPG CCCCCCCCCCCCCCC | 32.97 | - | |
258 (in isoform 2) | Phosphorylation | - | 12.27 | 24117733 | |
381 | Phosphorylation | DSRGPPPTDPYGRPP CCCCCCCCCCCCCCC | 56.21 | 28796482 | |
384 | Phosphorylation | GPPPTDPYGRPPPYD CCCCCCCCCCCCCCC | 28.69 | 28796482 | |
390 | Phosphorylation | PYGRPPPYDRGDYGP CCCCCCCCCCCCCCC | 24.85 | 28796482 | |
392 | Methylation | GRPPPYDRGDYGPPG CCCCCCCCCCCCCCC | 33.76 | - | |
395 | Phosphorylation | PPYDRGDYGPPGREM CCCCCCCCCCCCCCC | 34.06 | 28796482 | |
404 | Phosphorylation | PPGREMDTARTPLSE CCCCCCCCCCCCCCH | 19.41 | 29255136 | |
407 | Phosphorylation | REMDTARTPLSEAEF CCCCCCCCCCCHHHH | 26.56 | 29255136 | |
410 | Phosphorylation | DTARTPLSEAEFEEI CCCCCCCCHHHHHHH | 35.64 | 23927012 | |
418 | Sulfoxidation | EAEFEEIMNRNRAIS HHHHHHHHHHCHHHC | 4.33 | 28183972 | |
425 | Phosphorylation | MNRNRAISSSAISRA HHHCHHHCHHHHHHH | 19.77 | 18452278 | |
426 | Phosphorylation | NRNRAISSSAISRAV HHCHHHCHHHHHHHH | 20.06 | 18452278 | |
427 | Phosphorylation | RNRAISSSAISRAVS HCHHHCHHHHHHHHH | 23.88 | 18452278 | |
430 | Phosphorylation | AISSSAISRAVSDAS HHCHHHHHHHHHCCC | 17.57 | 20860994 | |
434 | Phosphorylation | SAISRAVSDASAGDY HHHHHHHHCCCCCCH | 26.86 | 21406692 | |
437 | Phosphorylation | SRAVSDASAGDYGSA HHHHHCCCCCCHHHH | 37.46 | 21406692 | |
441 | Phosphorylation | SDASAGDYGSAIETL HCCCCCCHHHHHHHH | 16.44 | 21406692 | |
443 | Phosphorylation | ASAGDYGSAIETLVT CCCCCHHHHHHHHHH | 21.61 | 21406692 | |
447 | Phosphorylation | DYGSAIETLVTAISL CHHHHHHHHHHHHHH | 22.03 | 21406692 | |
450 | Phosphorylation | SAIETLVTAISLIKQ HHHHHHHHHHHHHHH | 22.76 | 21406692 | |
453 | Phosphorylation | ETLVTAISLIKQSKV HHHHHHHHHHHHCCC | 22.90 | 24719451 | |
456 | Ubiquitination | VTAISLIKQSKVSAD HHHHHHHHHCCCCHH | 54.54 | 33845483 | |
459 | Ubiquitination | ISLIKQSKVSADDRC HHHHHHCCCCHHHHH | 37.40 | - | |
471 | Phosphorylation | DRCKVLISSLQDCLH HHHHHHHHHHHHHHH | 22.34 | 18452278 | |
476 | Glutathionylation | LISSLQDCLHGIESK HHHHHHHHHHHHHCC | 1.63 | 22555962 | |
482 | Phosphorylation | DCLHGIESKSYGSGS HHHHHHHCCCCCCCC | 25.61 | 26074081 | |
483 | Ubiquitination | CLHGIESKSYGSGSR HHHHHHCCCCCCCCH | 34.60 | 21963094 | |
484 | Phosphorylation | LHGIESKSYGSGSRR HHHHHCCCCCCCCHH | 43.96 | 26074081 | |
485 | Phosphorylation | HGIESKSYGSGSRRE HHHHCCCCCCCCHHH | 21.03 | 26074081 | |
487 | Phosphorylation | IESKSYGSGSRRERS HHCCCCCCCCHHHHH | 25.93 | 26074081 | |
489 | Phosphorylation | SKSYGSGSRRERSRE CCCCCCCCHHHHHHH | 29.84 | 26074081 | |
493 | Ubiquitination | GSGSRRERSRERDHS CCCCHHHHHHHHHHH | 38.92 | 33845483 | |
494 | Phosphorylation | SGSRRERSRERDHSR CCCHHHHHHHHHHHH | 33.47 | 30916345 | |
500 | Phosphorylation | RSRERDHSRSREKSR HHHHHHHHHHHHHHH | 35.92 | 30916345 | |
502 | Phosphorylation | RERDHSRSREKSRRH HHHHHHHHHHHHHHH | 48.05 | 33259812 | |
511 | Phosphorylation | EKSRRHKSRSRDRHD HHHHHHHHHHHHHHH | 29.39 | 30916345 | |
513 | Phosphorylation | SRRHKSRSRDRHDDY HHHHHHHHHHHHHHH | 45.70 | 23401153 | |
520 | Phosphorylation | SRDRHDDYYRERSRE HHHHHHHHHHHHHHH | 15.52 | 29449344 | |
520 | Ubiquitination | SRDRHDDYYRERSRE HHHHHHHHHHHHHHH | 15.52 | 21963094 | |
521 | Phosphorylation | RDRHDDYYRERSRER HHHHHHHHHHHHHHH | 17.00 | 29214152 | |
525 | Phosphorylation | DDYYRERSRERERHR HHHHHHHHHHHHHHH | 33.47 | 30916345 | |
539 | Phosphorylation | RDRDRDRDRERDRER HHHHHHHHHHHHHHH | 62.17 | 33259812 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPSF6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPSF6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-407, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-404, AND MASSSPECTROMETRY. |